Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic effects of doxazosin and ramipril in essential hypertension
2007-000631-25Phase 2Active
- Sponsor
- Karolinska Institutet
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of doxazosin and ramipril in essential hypertension (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Thrombin generation by prothrombin fragment 1+2 and Thrombin generation by thrombin-antithrombin complex. Started Apr 2010; status: active.
02
Drugs
doxazosinramipril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-000631-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000631-25.